Serveur d'exploration autour du libre accès en Belgique

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Delmastro M < Delorenzi M < Delpierre P

Mauro Delorenzi
Bioinformatics Core Facility, Swiss Institute of Bioinformatics (SIB), 1015, Lausanne, Switzerland
001646
Département de Formation et Recherche, Lausanne University Medical Centre, Switzerland
001646
Functional Genomics and Translational Research Unit (CS, SL, BH-K, CD), Translational Research and Medical Oncology Unit (CS, CD, DL, FC, MP), Jules Bordet Institute, Machine Learning Group (BH-K), Université Libre de Bruxelles, Brussels, Belgium; National Center of Competence in Research Molecular Oncology, Swiss Institute of Experimental Cancer Research (PW, PF, MD), Swiss Institute of Bioinformatics (PW, PF, VP, MD), CH-1066 Epalinges, Switzerland; Molecular Oncology Laboratory and Molecular Angiogenesis Laboratory, Cancer Research UK and the Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK (AH, SF); Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden (JS, JB); Department of Pathology, Uppsala University Hospital, Uppsala, Sweden (HN); Division of Diagnostic Oncology (HP, MJVdV), Division of Radiation Oncology (DN), The Netherlands Cancer Institute, Amsterdam, The Netherlands; International Drug Development Institute, Brussels, Belgium (MB)
000C21
International Drug Development Institute, Brussels, Belgium (MB, MA, FP); Institut Jules Bordet, Brussels, Belgium (SL, CS, FC, MJP); Netherlands Cancer Institute, Amsterdam, The Netherlands (LvV, ER); European Institute of Oncology and University of Milan School of Medicine, Milan, Italy (GV); National Center of Competence in Research Molecular Oncology, Swiss Institute of Experimental Cancer Research, Epalinges & the Swiss Institute of Bioinformatics, Lausanne, Switzerland (MD); Agendia B.V. Amsterdam, The Netherlands (LvV, AMG, AF); Institut Gustave Roussy, Villejuif, France (MSd'A); Karolinska Institute, Stockholm, Sweden (JB); Centre René Huguenin and Institut National de la Santé et de la Recherche Médicale, St Cloud, France (RL); Guy's Hospital, London, U.K. (PE); John Radcliffe Hospital, Oxford, U.K. (AH); European Organisation for the Research and Treatment of Cancer Data Center, Brussels, Belgium (JB, PT)
000F08
NONE
000C21
000F08
001646

<g>
<k>Delorenzi M</k>
<l>
<g>
<k>Mauro Delorenzi</k>
<l>
<g>
<k>
<mods:affiliation>Bioinformatics Core Facility, Swiss Institute of Bioinformatics (SIB), 1015, Lausanne, Switzerland</mods:affiliation>
</k>
<l>
<i>001646</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Département de Formation et Recherche, Lausanne University Medical Centre, Switzerland</mods:affiliation>
</k>
<l>
<i>001646</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>Functional Genomics and Translational Research Unit (CS, SL, BH-K, CD), Translational Research and Medical Oncology Unit (CS, CD, DL, FC, MP), Jules Bordet Institute, Machine Learning Group (BH-K), Université Libre de Bruxelles, Brussels, Belgium; National Center of Competence in Research Molecular Oncology, Swiss Institute of Experimental Cancer Research (PW, PF, MD), Swiss Institute of Bioinformatics (PW, PF, VP, MD), CH-1066 Epalinges, Switzerland; Molecular Oncology Laboratory and Molecular Angiogenesis Laboratory, Cancer Research UK and the Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK (AH, SF); Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden (JS, JB); Department of Pathology, Uppsala University Hospital, Uppsala, Sweden (HN); Division of Diagnostic Oncology (HP, MJVdV), Division of Radiation Oncology (DN), The Netherlands Cancer Institute, Amsterdam, The Netherlands; International Drug Development Institute, Brussels, Belgium (MB)</mods:affiliation>
</k>
<l>
<i>000C21</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>International Drug Development Institute, Brussels, Belgium (MB, MA, FP); Institut Jules Bordet, Brussels, Belgium (SL, CS, FC, MJP); Netherlands Cancer Institute, Amsterdam, The Netherlands (LvV, ER); European Institute of Oncology and University of Milan School of Medicine, Milan, Italy (GV); National Center of Competence in Research Molecular Oncology, Swiss Institute of Experimental Cancer Research, Epalinges & the Swiss Institute of Bioinformatics, Lausanne, Switzerland (MD); Agendia B.V. Amsterdam, The Netherlands (LvV, AMG, AF); Institut Gustave Roussy, Villejuif, France (MSd'A); Karolinska Institute, Stockholm, Sweden (JB); Centre René Huguenin and Institut National de la Santé et de la Recherche Médicale, St Cloud, France (RL); Guy's Hospital, London, U.K. (PE); John Radcliffe Hospital, Oxford, U.K. (AH); European Organisation for the Research and Treatment of Cancer Data Center, Brussels, Belgium (JB, PT)</mods:affiliation>
</k>
<l>
<i>000F08</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<mods:affiliation>NONE</mods:affiliation>
</k>
<l>
<i>000C21</i>
<i>000F08</i>
<i>001646</i>
</l>
<n>3</n>
<t>3</t>
</g>
</l>
<n>5</n>
<t>7</t>
</g>
</l>
<n>1</n>
<t>7</t>
</g>

Wicri

This area was generated with Dilib version V0.6.25.
Data generation: Thu Dec 1 00:43:49 2016. Site generation: Wed Mar 6 14:51:30 2024